Free Trial
ASX:RNO

Rhinomed (RNO) Stock Price, News & Analysis

About Rhinomed Stock (ASX:RNO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
452,773 shs
Average Volume
N/A
Market Capitalization
A$11.47 million
P/E Ratio
N/A
Dividend Yield
3.01%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rhinomed and its competitors with MarketBeat's FREE daily newsletter.

RNO Stock News Headlines

Insider Buyers Lose AU$435k As Rhinomed Sheds AU$1.4m
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Meredith George Bought 6.7% More Shares In Rhinomed \
See More Headlines

RNO Stock Analysis - Frequently Asked Questions

Rhinomed Limited (ASX:RNO) issued its quarterly earnings data on Thursday, February, 28th. The company reported ($0.02) EPS for the quarter. Rhinomed had a positive trailing twelve-month return on equity of 1,591.14% and a negative net margin of 145.98%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rhinomed investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Lowe's Companies (LOW), Energy Vault (NRGV) and Medicine Man Technologies (SHWZ).

Company Calendar

Last Earnings
2/28/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:RNO
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$10.91 million
Net Margins
-145.98%
Pretax Margin
N/A
Return on Equity
1,591.14%
Return on Assets
-101.64%

Debt

Debt-to-Equity Ratio
-93.28
Current Ratio
0.27
Quick Ratio
1.28

Sales & Book Value

Annual Sales
A$8.05 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.48
Book Value
A($0.02) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
286,780,000
Free Float
N/A
Market Cap
A$11.47 million
Optionable
Not Optionable
Beta
0.88
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:RNO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners